Back to Journals » Neuropsychiatric Disease and Treatment » Volume 1 » Issue 3

Bupropion SR in adults with ADHD: a short-term, placebo-controlled trial

Authors Frederick W Reimherr, Dawson W Hedges, Robert E Strong, Barrie K Marchant, Erika D Williams

Published 15 October 2005 Volume 2005:1(3) Pages 245—251

Frederick W Reimherr1, Dawson W Hedges1,2, Robert E Strong1, Barrie K Marchant1, Erika D Williams1

1University of Utah, Department of Psychiatry, Salt Lake City, UT, USA; 2Present address: Department of Psychology, Brigham Young University, Provo, UT, USA

Abstract: Increased attention has been given to the alternatives to stimulants in the treatment of attention deficit hyperactivity disorder (ADHD) in both adults and children. This short-term, double-blind trial was designed to evaluate the extended-release form of bupropion in adult subjects meeting DSM-IV and the Utah Diagnostic Criteria for ADHD. Outcome measures were the Clinical Global Impressions-Improvement (CGI-I) and the Wender-Reimherr Adult Attention Deficit Disorder Scale (WRAADDS), which assesses adult ADHD symptoms. Outcome (defined by the CGI-I, average WRAADDS scores, or a 50% improvement on the WRAADDS) favored bupropion SR over placebo, but achieved statistical significance on only one, post hoc measure. Other measures showed trends for improvement with bupropion. Given the small size of this study, these findings deserve further exploration.

Keywords: bupropion SR, ADHD, adult, controlled study

Download Article [PDF] 

Readers of this article also read:

Covalent IR820-PEG-diamine nanoconjugates for theranostic applications in cancer

Fernandez-Fernandez A, Manchanda R, Carvajal DA, Lei T, Srinivasan S, McGoron AJ

International Journal of Nanomedicine 2014, 9:4631-4648

Published Date: 6 October 2014

Evaluation of renal quantitative T2* changes on MRI following administration of ferumoxytol as a T2* contrast agent

Hedgire SS, McDermott S, Wojtkiewicz GR, Abtahi SM, Harisinghani M, Gaglia JL

International Journal of Nanomedicine 2014, 9:2101-2107

Published Date: 28 April 2014

Birdshot uveitis: current and emerging treatment options

Menezo V, Taylor SRJ

Clinical Ophthalmology 2014, 8:73-81

Published Date: 18 December 2013

Treatment of adults with attention-deficit/hyperactivity disorder

Dusan Kolar, Amanda Keller, Maria Golfinopoulos, Lucy Cumyn, Cassidy Syer, Lily Hechtman

Neuropsychiatric Disease and Treatment 2008, 4:107-121

Published Date: 8 February 2008

Clinical applications of perfluorocarbon nanoparticles for molecular imaging and targeted therapeutics

Trung D Tran, Shelton D Caruthers, Michael Hughes, John N Marsh, Tillmann Cyrus, et al

International Journal of Nanomedicine 2007, 2:515-526

Published Date: 15 January 2008

Guest Editorial: NDT goes Open Access || FREE PAPER ||

Roger M Pinder, Allan Young

Neuropsychiatric Disease and Treatment 2007, 3:285-286

Published Date: 15 July 2007

Rizatriptan in the treatment of migraine

Miguel JA Láinez

Neuropsychiatric Disease and Treatment 2006, 2:247-259

Published Date: 15 September 2006

Dietary approaches that delay age-related diseases

Arthur V Everitt, Sarah N Hilmer, Jennie C Brand-Miller, Hamish A Jamieson, A Stewart Truswell, Anita P Sharma, Rebecca S Mason, Brian J Morris, David G Le Couteur

Clinical Interventions in Aging 2006, 1:11-31

Published Date: 15 March 2006